OXC-BETA

Description

Adjuvants for use with vaccines; Animal feed additives and supplements; Anti-infective products for veterinary use; Anti-inflammatories; Dietary, nutritionals and food supplements; Nutritional supplements for general health and well-being; Dietary food supplements for general health and well-being; Medicated dermatological preparations and substances; Medicated skin care preparations; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplements for supporting immune function; Nutritional supplements for cats, dogs, horses, livestock; Pharmaceutical preparations for treatment of infectious diseases, namely, respiratory infections, eye infections; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of viral, respiratory, gastrointestinal, dermatological, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of bacteria-based diseases or disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of bacterial infections; Pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; Pharmaceutical preparations for the prevention and treatment of disorders of the immune system, Pharmaceutical preparations for treatment of respiratory diseases, disorders and infections; Pharmaceutical preparations for the treatment of inflammatory disorders and diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in gastroenterology; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Veterinary preparations for treatment of intestinal bacteria; Veterinary pharmaceutical preparations for animals and poultry to give newborn animals and birds a healthy start; Veterinary pharmaceutical preparations for respiratory and reproductive diseases in cattle; Veterinary pharmaceutical preparations for treatment of bacterial infections in dogs; Veterinary pharmaceutical preparations for the treatment of infectious diseases in poultry; Veterinary pharmaceutical preparations for treatment of infectious disease, namely, respiratory infections, eye infections, topical infections; Veterinary pharmaceutical preparations for the treatment of infectious diseases, namely, swine dysentery, bacterial enteritis, bluecomb, pneumonia; Veterinary pharmaceutical preparations for the treatment of swine bacterial infectious diseases; Veterinary pharmaceutical preparations for treatment of intestinal bacteria